Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.
Ticker SymbolZYXI
Company nameZynex Inc
IPO dateNov 27, 2002
CEO- -
Number of employees1000
Security typeOrdinary Share
Fiscal year-endNov 27
Address9655 Maroon Circle
CityENGLEWOOD
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code80112
Phone18004956670
Websitehttps://www.zynex.com/
Ticker SymbolZYXI
IPO dateNov 27, 2002
CEO- -
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data